Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/06/20 → 31/05/25 |
AZA: A multi-site phase 1/2 dose escalation/expansion trial combining azacitidine and defactinib for high-riskmyelodysplastic syndrome patients who fail to respond to azacitidine alone
- Pimanda, John E (PI)
- Polizzotto, Mark (PI)
- Campbell, Peter (CoI)
- Dawson, Mark (CoI)
- Hertzberg, Mark (CoI)
- Lock, Richard (CoI)
- Olivier, Jake (CoI)
- Unnikrishnan, Ashwin (CoI)
- Wei, Andrew (CoI)
Project: Research